| scholarly article | Q13442814 |
| P50 | author | Elisabetta Dejana | Q56099781 |
| Daniel J. Hicklin | Q110496406 | ||
| P2093 | author name string | Yan Wu | |
| Peter Bohlen | |||
| Fang Liao | |||
| Bridget Finnerty | |||
| Paul Kussie | |||
| Rajiv Bassi | |||
| Jacqueline F Doody | |||
| Jay Overholser | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| antibody | Q79460 | ||
| P304 | page(s) | 2567-2575 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability | |
| P478 | volume | 62 |
| Q27315862 | Adhesion molecule expression and function of primary endothelial cells in benign and malignant tissues correlates with proliferation |
| Q40998530 | Adrenomedullin blockade induces regression of tumor neovessels through interference with vascular endothelial-cadherin signalling |
| Q36296985 | Anti-apoptosis effects of vascular endothelial cadherin in experimental corneal neovascularization |
| Q37129915 | Antiangiogenic therapy in brain tumors |
| Q42366549 | Antitumor immunity induced by VE-cadherin modified DC vaccine |
| Q37328390 | Blood-based biomarkers for the optimization of anti-angiogenic therapies |
| Q24673319 | Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization |
| Q39735980 | Clinical use of TNF revisited: improving penetration of anti-cancer agents by increasing vascular permeability |
| Q34078666 | Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling |
| Q36322698 | Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis |
| Q38048760 | Endothelial cell-to-cell junctions: adhesion and signaling in physiology and pathology |
| Q28303395 | Endothelial progenitor cells: identity defined? |
| Q42605259 | Epithelial protein lost in neoplasm (EPLIN) interacts with α-catenin and actin filaments in endothelial cells and stabilizes vascular capillary network in vitro. |
| Q28384090 | Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes |
| Q45055095 | Improved efficacy of therapeutic vaccination with viable human umbilical vein endothelial cells against murine melanoma by introduction of OK432 as adjuvant |
| Q39888963 | Inhibition of B16 melanoma growth and metastasis in C57BL mice by vaccination with a syngeneic endothelial cell line |
| Q33915046 | Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth |
| Q36248811 | Mechanism of Collaborative Enhancement of Binding of Paired Antibodies to Distinct Epitopes of Platelet Endothelial Cell Adhesion Molecule-1. |
| Q37442498 | Mechanisms and targets for angiogenic therapy after stroke |
| Q35110762 | Molecular pathology of tumor metastasis III. Target array and combinatorial therapies |
| Q36717794 | Nascent endothelium initiates Th2 polarization of asthma |
| Q58557198 | Restriction of drug transport by the tumor environment |
| Q27303072 | Selective alpha-particle mediated depletion of tumor vasculature with vascular normalization |
| Q92362875 | Structure-Based Virtual Screening Allows the Identification of Efficient Modulators of E-Cadherin-Mediated Cell-Cell Adhesion |
| Q35606197 | Suppression of retinal neovascularization with an antagonist to vascular endothelial cadherin |
| Q33568457 | The human VE-cadherin promoter is subjected to organ-specific regulation and is activated in tumour angiogenesis |
| Q37743207 | Tumor angiogenesis: insights and innovations |
| Q35102828 | VE-cadherin expression and clustering maintain low levels of survivin in endothelial cells |
| Q33926020 | VEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis |
| Q37309920 | Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma |
| Q48171757 | Vascular endothelial effects of collaborative binding to platelet/endothelial cell adhesion molecule-1 (PECAM-1). |
| Q33556970 | Vascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues |
| Q42546329 | Wnt signaling mediates pathological vascular growth in proliferative retinopathy |
| Q33840402 | p38 MAP kinase is necessary for melanoma-mediated regulation of VE-cadherin disassembly |
Search more.